Literature DB >> 18088269

Drug resistance in epilepsy: why is a simple explanation not enough?

Wolfgang Löscher, Graeme J Sills.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18088269     DOI： 10.1111/j.1528-1167.2007.01260_2.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN： 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  14 in total

1.  New developments in antiepileptic drug resistance: an integrative view.

Authors:  Dieter Schmidt; Wolfgang Löscher
Journal:  Epilepsy Curr       Date:  2009 Mar-Apr       Impact factor: 7.500

2.  Intrinsic severity as a determinant of antiepileptic drug refractoriness.

Authors:  Michael A Rogawski; Michael R Johnson
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

Review 3.  Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.

Authors:  Chaitali Ghosh; Vikram Puvenna; Jorge Gonzalez-Martinez; Damir Janigro; Nicola Marchi
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

Review 4.  Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.

Authors:  Stefan Wolking; Elke Schaeffeler; Holger Lerche; Matthias Schwab; Anne T Nies
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447

5.  Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains.

Authors:  Chaitali Ghosh; Mohammed Hossain; Vikram Puvenna; Jorge Martinez-Gonzalez; Andreas Alexopolous; Damir Janigro; Nicola Marchi
Journal:  Epilepsia       Date:  2013-07-19       Impact factor: 5.864

Review 6.  What non-neuronal mechanisms should be studied to understand epileptic seizures?

Authors:  Damir Janigro; Matthew C Walker
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 7.  Use and Future Prospects of in Vivo Microdialysis for Epilepsy Studies.

Authors:  Alexander G Zestos; Hiram Luna-Munguia; William C Stacey; Robert T Kennedy
Journal:  ACS Chem Neurosci       Date:  2018-07-23       Impact factor: 4.418

8.  Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells.

Authors:  Rong Zhang; Ryuta Saito; Ichiyo Shibahara; Shinichiro Sugiyama; Masayuki Kanamori; Yukihiko Sonoda; Teiji Tominaga
Journal:  J Neurooncol       Date:  2015-11-04       Impact factor: 4.130

9.  (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.

Authors:  Jeih-San Liow; Sami S Zoghbi; Shuo Hu; Matthew D Hall; Christina S Hines; H Umesha Shetty; Maria D Araneta; Emily M Page; Victor W Pike; William C Kreisl; Peter Herscovitch; Michael M Gottesman; William H Theodore; Robert B Innis
Journal:  Neuroimage       Date:  2016-05-19       Impact factor: 6.556

10.  [11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats.

Authors:  Joost Verbeek; Jonas Eriksson; Stina Syvänen; Maaike Labots; Elizabeth C M de Lange; Rob A Voskuyl; Martinus P J Mooijer; Marissa Rongen; Adriaan A Lammertsma; Albert D Windhorst
Journal:  EJNMMI Res       Date:  2012-07-02       Impact factor: 3.138
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.